ID

14655

Description

Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00219908

Lien

https://clinicaltrials.gov/show/NCT00219908

Mots-clés

  1. 25/04/2016 25/04/2016 -
Téléchargé le

25 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00219908

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00219908

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age : 18-45 years,
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
clinical disease satisfying the poser criteria (amdmt n°4)
Description

Clinical disease

Type de données

boolean

Alias
UMLS CUI [1]
C0012634
relapsing-remitting disease (amdmt n°4)
Description

Relapsing-Remitting Multiple Sclerosis

Type de données

boolean

Alias
UMLS CUI [1]
C0751967
at least 2 exacerbations within the preceding 12 months, having left sequelae,
Description

MS exacerbation

Type de données

boolean

Alias
UMLS CUI [1]
C0581392
mri activity at inclusion expressed by at least one gadolinium-enhanced lesion (cranial mri with 0.1mmol/kg gadolinium),
Description

MRI with gadolinium

Type de données

boolean

Alias
UMLS CUI [1,1]
C0024485
UMLS CUI [1,2]
C0016911
a significant disability at inclusion: edss score between 2.5 and 5.5 (amdt n° 4)
Description

EDSS score

Type de données

boolean

Alias
UMLS CUI [1]
C0451246
written informed consent
Description

Informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy and breast-feeding
Description

Gynaecological status

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
use of an insufficiency effective contraceptive method,
Description

Contraception

Type de données

boolean

Alias
UMLS CUI [1]
C0700589
general immunosuppressive therapy using cyclophosphamide, mitoxantrone,or total lymphoid irradiation
Description

iImunosuppressive therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0021079
treatment with azathioprine during the 3 months preceding the study
Description

Azathioprine

Type de données

boolean

Alias
UMLS CUI [1]
C0004482
clinical relapse or intensive corticosteroid treatment within the 30 days preceding inclusion,
Description

Relapse and corticosteroid treatment

Type de données

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2]
C0149783
associated disease (psychiatric disorder, depressive statenot controlled by appropriate drug therapy, history of heart disease at inclusion examination
Description

Comorbidity

Type de données

boolean

Alias
UMLS CUI [1]
C0009488

Similar models

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00219908

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age : 18-45 years,
boolean
C0001779 (UMLS CUI [1])
Clinical disease
Item
clinical disease satisfying the poser criteria (amdmt n°4)
boolean
C0012634 (UMLS CUI [1])
Relapsing-Remitting Multiple Sclerosis
Item
relapsing-remitting disease (amdmt n°4)
boolean
C0751967 (UMLS CUI [1])
MS exacerbation
Item
at least 2 exacerbations within the preceding 12 months, having left sequelae,
boolean
C0581392 (UMLS CUI [1])
MRI with gadolinium
Item
mri activity at inclusion expressed by at least one gadolinium-enhanced lesion (cranial mri with 0.1mmol/kg gadolinium),
boolean
C0024485 (UMLS CUI [1,1])
C0016911 (UMLS CUI [1,2])
EDSS score
Item
a significant disability at inclusion: edss score between 2.5 and 5.5 (amdt n° 4)
boolean
C0451246 (UMLS CUI [1])
Informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Gynaecological status
Item
pregnancy and breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Contraception
Item
use of an insufficiency effective contraceptive method,
boolean
C0700589 (UMLS CUI [1])
iImunosuppressive therapy
Item
general immunosuppressive therapy using cyclophosphamide, mitoxantrone,or total lymphoid irradiation
boolean
C0021079 (UMLS CUI [1])
Azathioprine
Item
treatment with azathioprine during the 3 months preceding the study
boolean
C0004482 (UMLS CUI [1])
Relapse and corticosteroid treatment
Item
clinical relapse or intensive corticosteroid treatment within the 30 days preceding inclusion,
boolean
C0277556 (UMLS CUI [1])
C0149783 (UMLS CUI [2])
Comorbidity
Item
associated disease (psychiatric disorder, depressive statenot controlled by appropriate drug therapy, history of heart disease at inclusion examination
boolean
C0009488 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial